CNS Pharmaceuticals (CNSP) Other Accumulated Expenses (2018)

CNS Pharmaceuticals (CNSP) has 1 years of Other Accumulated Expenses data on file, last reported at $763249.0 in Q4 2018.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $763249.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $763249.0 (changed N/A YoY) and the FY2018 annual result came in at $763249.0, changed N/A from the prior year.
• Other Accumulated Expenses was little changed at $763249.0 in Q4 2018.
• In the past five years, Other Accumulated Expenses ranged from a high of $763249.0 in Q4 2018 to a low of $763249.0 in Q4 2018.